Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn's disease: a real-world multicenter Brazilian study.
Parra RS, Chebli JMF, Queiroz NSF, Damião AOMC, de Azevedo MFC, Chebli LA, Bertges ER, Alves Junior AJT, Ambrogini Junior O, da Silva BLPS, Lubini M, Bafutto M, Flores C, Vilela EG, Boratto SF, Gasparetti Junior NLT, Steinwurz F, Carvalho NS, Féres O, da Rocha JJR.
Parra RS, et al. Among authors: da silva blps.
BMC Gastroenterol. 2022 Apr 21;22(1):199. doi: 10.1186/s12876-022-02280-3.
BMC Gastroenterol. 2022.
PMID: 35448949
Free PMC article.